Search

Angela R Coxon

from Moorpark, CA
Age ~57
Get Report
Also known as:
Angela Gaxon, Angela Coxen
Phone and address:
11136 Broadview Dr, Moorpark, CA 93021
Connected to:
Carolyn J Coxon, 81Christian C Coxon, 51Gary R Coxon, 82Greg Coxon, 62Joe C Coxon, 105Michael D Coxon, 41Stephanie E Coxon, 36Steve D Coxon, 63Mary F Coxsey, 73Tina W Coxsey, 68

Angela Coxon Phones & Addresses

  • 11136 Broadview Dr, Moorpark, CA 93021
  • 12004 Bubbling Brook St, Moorpark, CA 93021
  • 587 Ventu Park Rd, Newbury Park, CA 91320
  • Westlake Village, CA
  • 11217 Sierra Pass Pl, Chatsworth, CA 91311 (818) 576-9332
  • 25 Goodrich Rd, Jamaica Plain, MA 02130 (617) 522-3229
  • Cambridge, MA
  • Los Angeles, CA

Work

Company: Amgen Mar 2012 Address: Thousand Oaks, CA Position: Executive director

Education

Degree: D. Phil. School / High School: University of Oxford

Skills

Drug Discovery • Biotechnology • Oncology • Drug Development • Biopharmaceuticals • Biomarkers • Life Sciences • Pharmaceutical Industry • Clinical Development • Cell Biology • Clinical Trials • R&D • Translational Medicine • Assay Development • Molecular Biology • Lifesciences • Diabetes • Organic Chemistry

Industries

Biotechnology

Resumes

Resumes

Angela Coxon Photo 1

Vice President Oncology Research

View page
Location:
Newbury Park, CA
Industry:
Biotechnology
Work:
Amgen - Thousand Oaks, CA since Mar 2012
Executive Director
Education:
University of Oxford
D. Phil.
Skills:
Drug Discovery
Biotechnology
Oncology
Drug Development
Biopharmaceuticals
Biomarkers
Life Sciences
Pharmaceutical Industry
Clinical Development
Cell Biology
Clinical Trials
R&D
Translational Medicine
Assay Development
Molecular Biology
Lifesciences
Diabetes
Organic Chemistry

Publications

Us Patents

Specific Binding Agents To Hepatocyte Growth Factor

View page
US Patent:
20050118643, Jun 2, 2005
Filed:
Jul 16, 2004
Appl. No.:
10/893576
Inventors:
Teresa Burgess - Ventura CA, US
Angela Coxon - Moorpark CA, US
Larry Green - San Francisco CA, US
Ke Zhang - Bethesda MD, US
International Classification:
G01N033/53
C07K014/74
C07K016/28
US Classification:
435007100, 530350000, 530388220
Abstract:
Specific binding agents that interact with hepatocyte growth factor (HGF) are described. Methods of treating cancer by administering a pharmaceutically effective amount of a specific binding agent to HGF are described. Methods of detecting the amount of HGF in a sample using a specific binding agent to HGF are described.

Combinations Vegf(R) Inhibitors And Hepatocyte Growth Factor (C-Met) Inhibitors For The Treatment Of Cancer

View page
US Patent:
20110104161, May 5, 2011
Filed:
May 14, 2009
Appl. No.:
12/992359
Inventors:
Teresa L. Burgess - Ventura CA, US
Angela Coxon - Moorpark CA, US
Isabelle Dussault - Westlake Village CA, US
Anthony J. Polverino - Bainbridge Island WA, US
Darrin Beaupre - Simi Valley CA, US
International Classification:
A61K 39/395
A61P 35/00
A61K 31/437
A61K 31/5355
US Classification:
4241331, 4241721, 514300, 5142355
Abstract:
This invention is in the field of pharmaceutical agents and specifically relates to compounds, compositions, uses and methods for treating cancer, by—combining VEGF(R) inhibitors and inhibitors of HGF/SF:c-Met.

Biomarkers And Use Of Met Inhibitor For Treatment Of Cancer

View page
US Patent:
20170182016, Jun 29, 2017
Filed:
Apr 3, 2015
Appl. No.:
15/300690
Inventors:
- Thousand Oaks CA, US
Angela COXON - Moorpark CA, US
Zhiqiang DU - Thousand Oaks CA, US
Paul HUGHES - Santa Monica CA, US
Robert LOBERG - Thousand Oaks CA, US
Gift NGARMCHAMNANRITH - Thousand Oaks CA, US
Beate SABLE - Newbury Park CA, US
International Classification:
A61K 31/4375
C12Q 1/68
Abstract:
The present invention relates to methods of therapeutic treatment of cancer using selective tyrosine kinase inhibitors and cancer biomarkers, such as MET amplification and high Met expression for patient selection.

Combinations Vegf(R) Inhibitors And Hepatocyte Growth Factor (C-Met) Inhibitors For The Treatment Of Cancer

View page
US Patent:
20140243339, Aug 28, 2014
Filed:
Feb 28, 2014
Appl. No.:
14/194431
Inventors:
- Thousand Oaks CA, US
Angela Coxon - Moorpark CA, US
Isabelle Dussault - Westlake Village CA, US
Anthony J. Polverino - Bainbridge Island WA, US
Darrin Beaupre - Simi Valley CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/5377
A61K 31/506
A61K 31/438
A61K 31/444
US Classification:
5142365, 514333, 514248, 514312, 514318
Abstract:
This invention is in the field of pharmaceutical agents and specifically relates to compounds, compositions, uses and methods for treating cancer, by combining VEGF(R) inhibitors and inhibitors of HGF/SF:c-Met.
Control profile
Angela R Coxon from Moorpark, CA, age ~57 Get Report